Evidence map›Paper›PMID 41925139›Full record

ArticleDatabase : the journal of biological databases and curation2026

MASH-GA: a manually curated cross-species transcriptomic database for metabolic-associated steatohepatitis.

Yong Wang, Ke Ding, Beicheng Sun, Qingxiang Xu, Weiting Zheng, Lei Liu, Jian Wang, Kanghui Liu, Jinyao Zhang, Wenjie Zhang

Abstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yong WangDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0001-9812-8384
Ke DingDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Beicheng SunDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Qingxiang XuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Weiting ZhengDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Lei LiuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jian WangDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-0096-0875
Kanghui LiuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jinyao ZhangDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Wenjie ZhangDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

Distinguished Young Scholar of Anhui Provincial Department of Education 2024AH020008Health Research Program of Anhui AHWJ2024BAc20031National Natural Science Foundation of China 82371850Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0502003Provincial Clinical Medical Research Translational Special Project 202527c10020053
6 · The paper itself

Abstract

Metabolic dysfunction-associated steatohepatitis (MASH), formerly called NASH, is a progressive form of fatty liver disease closely linked to metabolic dysregulation. It has become a leading cause of liver failure and liver transplantation worldwide. Despite its growing clinical significance, there is currently no centralized, publicly accessible, cross-cohort and cross-species transcriptomic database specifically dedicated to MASH. To address this gap, we developed MASH-GA (MASH-Genomic Atlas; https://mashga.com), the first and only database in the fatty liver research field that systematically integrates transcriptomic data across human cohorts and mouse models. MASH-GA contains 45 human transcriptomic datasets (2740 samples) from 17 countries and 126 mouse datasets (1950 samples) covering major MASH models. The platform provides a range of unique features, including integrated weighted gene coexpression network analysis (WGCNA), cross-model classification and comparison of mouse datasets, multigene correlation analysis and pairwise coexpression exploration, and interactive visualizations (e.g. boxplots and correlation plots). Human and mouse data are presented in separate, intuitively navigable modules. As the only standardized, multicohort, cross-species MASH transcriptomic database currently available, MASH-GA enables reproducible data exploration, informed model selection, and the identification of regulatory modules. It is therefore a valuable resource for researchers in hepatology, metabolic disease, and systems biology. Database URL:  https://mashga.com.

Indexed as

Databases, GeneticData CurationFatty LiverNon-alcoholic Fatty Liver DiseaseTranscriptomeAnimalsBiocurationGene Expression ProfilingHumansMice

Identifiers

PMID41925139
PMCPMC13044705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.